Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

45.65p
   
  • Change Today:
    -0.100p
  • 52 Week High: 49.55p
  • 52 Week Low: 29.35p
  • Currency: UK Pounds
  • Shares Issued: 540.57m
  • Volume: 678,755
  • Market Cap: £246.77m
  • RiskGrade: 119
  • Beta: 0.95

Alliance Pharma COO stepping down, position to be disestablished

By Josh White

Date: Tuesday 23 Jul 2024

LONDON (ShareCast) - (Sharecast News) - Healthcare products group Alliance Pharma announced on Tuesday that its chief operating officer Jeyan Heper would leave the company on 31 August.
The AIM-traded firm said Heper joined on 1 February 2023, playing a significant role in identifying growth opportunities in international consumer healthcare markets and assisting the board and senior executive team in developing strategies for markets, especially in China and the US.

In a move to accelerate globalisation, bring consumers closer to the core of the business, and streamline the management structure, the board said it had decided to eliminate the COO position.

"I want to thank Jeyan for his contribution to Alliance, providing stability and valuable international consumer healthcare insights as we continue on our journey to transform to a high performing consumer healthcare company, built on a portfolio of leading, trusted and proven brands," said chief executive officer Nick Sedgwick.

"We wish him well in his future endeavours."

At 1140 BST, shares in Alliance Pharma were down 0.54% at 36.8p.

Reporting by Josh White for Sharecast.com.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 45.65p
Change Today -0.100p
% Change -0.22 %
52 Week High 49.55p
52 Week Low 29.35p
Volume 678,755
Shares Issued 540.57m
Market Cap £246.77m
Beta 0.95
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
12.17% below the market average12.17% below the market average12.17% below the market average12.17% below the market average12.17% below the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Price Trend
48.60% above the market average48.60% above the market average48.60% above the market average48.60% above the market average48.60% above the market average
67.35% above the sector average67.35% above the sector average67.35% above the sector average67.35% above the sector average67.35% above the sector average
Income Not Available
Growth
38.67% below the market average38.67% below the market average38.67% below the market average38.67% below the market average38.67% below the market average
31.25% below the sector average31.25% below the sector average31.25% below the sector average31.25% below the sector average31.25% below the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 3
Sell 0
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 02-Jan-2025

Time Volume / Share Price
15:39 12 @ 45.56p
15:23 3,250 @ 45.70p
15:06 2,641 @ 45.80p
15:00 38,193 @ 45.37p
14:52 5 @ 45.27p

Alliance Pharma Key Personnel

CFO Andrew Franklin
Chair Camillo Pane
CEO Nick Sedgwick

Top of Page